Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Payables (2020 - 2025)

Historic Payables for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $4.6 million.

  • NeuroPace's Payables rose 11250.0% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 11250.0%. This contributed to the annual value of $3.0 million for FY2024, which is 2667.24% up from last year.
  • NeuroPace's Payables amounted to $4.6 million in Q3 2025, which was up 11250.0% from $4.7 million recorded in Q2 2025.
  • NeuroPace's Payables' 5-year high stood at $4.7 million during Q2 2025, with a 5-year trough of $968000.0 in Q2 2021.
  • Moreover, its 5-year median value for Payables was $2.1 million (2022), whereas its average is $2.3 million.
  • In the last 5 years, NeuroPace's Payables plummeted by 1790.84% in 2023 and then skyrocketed by 11250.0% in 2025.
  • NeuroPace's Payables (Quarter) stood at $1.4 million in 2021, then soared by 55.81% to $2.1 million in 2022, then grew by 8.62% to $2.3 million in 2023, then rose by 26.67% to $3.0 million in 2024, then skyrocketed by 55.38% to $4.6 million in 2025.
  • Its last three reported values are $4.6 million in Q3 2025, $4.7 million for Q2 2025, and $4.0 million during Q1 2025.